Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoYong Tao, Zheng‐Yi Chen, Yiran Li et al.|Nature Communications|2023Cited by 49
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoV. Alvarez, Zheng‐Yi Chen, Yong Tao et al.|Research Square|2022Cited by 0